$0.71 EPS Expected for Colgate-Palmolive (NYSE:CL) This Quarter

Equities research analysts forecast that Colgate-Palmolive (NYSE:CL) will report earnings per share of $0.71 for the current fiscal quarter, Zacks reports. Six analysts have provided estimates for Colgate-Palmolive’s earnings, with the highest EPS estimate coming in at $0.71 and the lowest estimate coming in at $0.70. Colgate-Palmolive reported earnings per share of $0.72 during the same quarter last year, which suggests a negative year-over-year growth rate of 1.4%. The company is expected to announce its next quarterly earnings report on Friday, October 25th.

On average, analysts expect that Colgate-Palmolive will report full-year earnings of $2.84 per share for the current financial year, with EPS estimates ranging from $2.83 to $2.85. For the next year, analysts anticipate that the company will post earnings of $3.06 per share, with EPS estimates ranging from $3.00 to $3.13. Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that cover Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, July 26th. The company reported $0.72 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a net margin of 14.77% and a negative return on equity of 10,821.98%. The company had revenue of $3.87 billion during the quarter, compared to analysts’ expectations of $3.88 billion. During the same quarter in the previous year, the company earned $0.77 earnings per share. The firm’s revenue for the quarter was down .5% on a year-over-year basis.

A number of research firms have weighed in on CL. Piper Jaffray Companies began coverage on shares of Colgate-Palmolive in a report on Tuesday. They issued an “overweight” rating for the company. UBS Group lifted their price objective on shares of Colgate-Palmolive from $80.00 to $82.00 and gave the company a “buy” rating in a report on Monday, July 29th. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $77.00 price objective for the company. in a report on Friday, June 7th. Macquarie lifted their price objective on shares of Colgate-Palmolive from $65.00 to $72.00 and gave the company a “neutral” rating in a report on Monday, April 29th. Finally, Bank of America set a $80.00 price objective on shares of Colgate-Palmolive and gave the company a “buy” rating in a report on Friday, July 12th. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and six have assigned a buy rating to the company’s stock. Colgate-Palmolive currently has a consensus rating of “Hold” and an average price target of $73.13.

CL traded up $0.91 on Friday, reaching $72.28. The stock had a trading volume of 2,463,500 shares, compared to its average volume of 3,782,616. Colgate-Palmolive has a 12-month low of $57.41 and a 12-month high of $76.41. The company has a current ratio of 1.13, a quick ratio of 0.78 and a debt-to-equity ratio of 32.25. The business’s 50-day moving average price is $72.54 and its two-hundred day moving average price is $69.91. The company has a market cap of $62.02 billion, a P/E ratio of 24.34, a price-to-earnings-growth ratio of 4.54 and a beta of 0.76.

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Thursday, July 18th were paid a dividend of $0.43 per share. The ex-dividend date of this dividend was Wednesday, July 17th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.38%. Colgate-Palmolive’s dividend payout ratio is currently 57.91%.

In other news, VP Philip G. Shotts sold 8,919 shares of the business’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $71.05, for a total transaction of $633,694.95. Following the completion of the sale, the vice president now owns 50,399 shares of the company’s stock, valued at $3,580,848.95. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Ian M. Cook sold 19,500 shares of the business’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $71.21, for a total transaction of $1,388,595.00. Following the sale, the insider now directly owns 1,107,742 shares of the company’s stock, valued at approximately $78,882,307.82. The disclosure for this sale can be found here. Insiders have sold 564,285 shares of company stock valued at $40,530,290 in the last three months. Corporate insiders own 1.14% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in Colgate-Palmolive by 1.4% during the second quarter. Vanguard Group Inc. now owns 76,502,840 shares of the company’s stock worth $5,482,958,000 after acquiring an additional 1,056,530 shares during the last quarter. BlackRock Inc. boosted its position in Colgate-Palmolive by 0.5% during the second quarter. BlackRock Inc. now owns 60,205,815 shares of the company’s stock worth $4,314,949,000 after acquiring an additional 279,887 shares during the last quarter. Bank of New York Mellon Corp boosted its position in Colgate-Palmolive by 2.9% during the second quarter. Bank of New York Mellon Corp now owns 20,354,779 shares of the company’s stock worth $1,458,828,000 after acquiring an additional 573,566 shares during the last quarter. Northern Trust Corp boosted its position in Colgate-Palmolive by 1.4% during the first quarter. Northern Trust Corp now owns 10,906,808 shares of the company’s stock worth $747,553,000 after acquiring an additional 146,144 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in Colgate-Palmolive by 7.9% during the fourth quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock worth $626,200,000 after acquiring an additional 768,550 shares during the last quarter. Hedge funds and other institutional investors own 75.64% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Recommended Story: Cost of Capital

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.